Advisory Services Network’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.1K Buy
+1,000
New +$55.7K ﹤0.01% 2574
2025
Q4
Sell
-700
Closed -$33.6K 4283
2025
Q3
$33.6K Buy
+700
New +$31.3K ﹤0.01% 2698
2024
Q1
Sell
-700
Closed -$29.1K 3690
2023
Q4
$29.1K Buy
+700
New +$26.5K ﹤0.01% 2314
2023
Q2
Sell
-700
Closed -$28.7K 3688
2023
Q1
$28.7K Hold
700
﹤0.01% 2328
2022
Q4
$28.7K Buy
+700
New +$29.1K ﹤0.01% 2267
2021
Q3
Sell
-700
Closed -$36K 3255
2021
Q2
$36K Buy
+700
New +$35.1K ﹤0.01% 2170
2021
Q1
Sell
-2,900
Closed -$151K 2976
2020
Q4
$151K Sell
2,900
-9,400
-76% -$449K 0.01% 1160
2020
Q3
$535K Buy
12,300
+300
+3% +$13.1K 0.03% 604
2020
Q2
$516K Buy
12,000
+11,200
+1,400% +$463K 0.03% 589
2020
Q1
$29K Buy
800
+100
+14% +$4.26K ﹤0.01% 1659
2019
Q4
$32K Hold
700
﹤0.01% 1755
2019
Q3
$28K Hold
700
﹤0.01% 1649
2019
Q2
$28K Sell
700
-90
-11% -$3.54K ﹤0.01% 1647
2019
Q1
$33K Hold
790
﹤0.01% 1402
2018
Q4
$29K Sell
790
-176
-18% -$7.51K ﹤0.01% 1346
2018
Q3
$47K Buy
966
+1
+0.1% +$47 ﹤0.01% 1257
2018
Q2
$44K Hold
965
﹤0.01% 1264
2018
Q1
$40K Sell
965
-650
-40% -$28.3K ﹤0.01% 1407
2017
Q4
$70K Buy
1,615
+194
+14% +$8.25K 0.01% 1121
2017
Q3
$60K Sell
1,421
-89
-6% -$3.77K 0.01% 1035
2017
Q2
$65K Sell
1,510
-94
-6% -$3.96K 0.01% 968
2017
Q1
$67K Buy
+1,604
New +$65.4K 0.01% 912
2016
Q3
$73K Sell
1,648
-199
-11% -$9.04K 0.01% 758
2016
Q2
$77K Hold
1,847
0.02% 675
2016
Q1
$74K Buy
1,847
+1
+0.1% +$42 0.02% 573
2015
Q4
$95K Sell
1,846
-170
-8% -$8.66K 0.03% 451
2015
Q3
$95K Sell
2,016
-300
-13% -$18.1K 0.03% 406
2015
Q2
$145K Sell
2,316
-74
-3% -$4.61K 0.04% 324
2015
Q1
$146K Hold
2,390
0.04% 327
2014
Q4
$134K Buy
+2,390
New +$131K 0.04% 288
2014
Q1
Sell
-1,200
Closed -$53K 828
2013
Q4
$53K Buy
+1,200
New +$50K 0.03% 310

Other funds holding XPH

Advisory Services Network's XPH Position: Q1 2026 in Review

Advisory Services Network opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2026: 1,000 shares worth $54.1K. The stake represents ﹤0.01% of the portfolio and ranks #2574 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in XPH as recently as Q3 2025.

Advisory Services Network first reported a position in XPH in Q4 2013 and has held it in 31 quarters since. The position peaked at $535K in Q3 2020. 82 funds tracked by Wall St. Rank hold XPH as of Q1 2026.

  • Advisory Services Network held 1,000 shares of State Street SPDR S&P Pharmaceuticals ETF worth $54.1K as of Q1 2026.
  • State Street SPDR S&P Pharmaceuticals ETF was a new Advisory Services Network position in Q1 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #2574 holding.
  • Advisory Services Network first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2013 and has held it in 31 quarters since.
  • Advisory Services Network's State Street SPDR S&P Pharmaceuticals ETF position peaked at $535K in Q3 2020.
  • 82 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.